Orphan Drugs- Development Trends and Strategies

An orphan drug can be determined as one that is used to handle an orphan disease. For example, haem arginate, used to control small cintermittent porphyria, variegate porphyria, and hereditary coproporphyria is an orphan drug. A medicinal product which is came into the source as orphan drug is one that has been developed especially to treat a rare medical condition which is found, the condition itself being referred to as “orphan disease.” It may be defined as drugs that are not evolved by the pharmaceutical industry for economic reasons but which respond to public.

  • Acute intermittent porphyria
  • Variegate porphyria

Related Conference of Orphan Drugs- Development Trends and Strategies

April 16-17, 2025

9th International Conference on Internal Medicine

Berlin, Germany
May 12-13, 2025

19th International Conference on Obesity Medicine

Toronto, Canada
June 24-25, 2025

3rd Global Summit on HIV-AIDS and STDs

Chicago, USA
July 21-22, 2025

11th World Congress on Anesthesia and Critical Care

Aix-en-Provence, France
July 21-22, 2025

24th International Conference on Genomics and Molecular Biology

Aix-en-Provence, France
August 07-08, 2025

12th World Summit on Epilepsy and Bipolar Disorders

Paris, France
August 25-26, 2025

8th International Conference on Community Nursing and Public Health

Singapore City, Singapore
September 22-23, 2025

39th International Conference on Cancer Science & Therapy

Amsterdam, Netherlands
October 16-17, 2025

19th International Conference on Pathology and Laboratory Medicine

Aix-en-Provence, France
November 03-04, 2025

5th World Medicine Congress

Rome, Italy

Orphan Drugs- Development Trends and Strategies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in